BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Ortho Clinical Diagnostics Announces Two Next Generation Clinical Diagnostic Platforms Now Available in Europe


1/15/2009 6:38:25 AM

HIGH WYCOMBE, England, January 15 /PRNewswire/ -- Ortho Clinical Diagnostics today announced commercial availability in Europe(*) for two new clinical laboratory systems, the flagship VITROS® 5600 Integrated System and the high-capacity VITROS® 3600 Immunodiagnostic System. These next generation diagnostic platforms are uniquely designed based on world-class VITROS® technologies to address the needs of the modern clinical laboratory, giving patients and clinicians high-quality and reliable test results.

Workflow data and input from 60 clinical laboratories worldwide drove the innovative designs of the VITROS® 5600 and 3600 Systems. Both instruments incorporate proven VITROS® technologies and use the same reagents as other VITROS® platforms thereby maintaining the same degree of accuracy. The compact systems do not have any water or drainage requirements, making the most of limited lab space while allowing flexibility in instrument location.

"Our mission has always been to give health professionals the highest quality tools to determine the best treatment. The introduction of the VITROS® 5600 Integrated System and VITROS® 3600 Immunodiagnostic System continues this mission with next generation instruments that have a broad, world class menu of assays and the capacity to support future high-impact tests," said David Atkins, PhD, Vice President for Ortho Clinical Diagnostics, EMEA. "Ortho Clinical Diagnostics is committed to developing advanced medical tests through our investment in specific disease-state biomarkers in reproductive health, oncology, cardiology and metabolic diseases."

About the VITROS® 5600 Integrated System

The VITROS® 5600 System is designed to integrate clinical chemistry and immunoassay testing to increase laboratory productivity and can perform more than 100 different chemistry, immunoassay and infectious disease assays on a single, high- quality system. In addition to its current broad menu including user-defined applications, the VITROS® 5600 Integrated System will have the capability to run future tests for earlier detection of diseases.

The VITROS® 5600 System incorporates a sample-centred processing approach, where individual samples are accessed independently and in parallel for chemistry and immunoassay testing. This approach can optimise turnaround time and productivity by intelligently accounting for variable sample and test mixes, eliminating the need to split the sample on the analyser or move sample trays between modules.

About the VITROS® 3600 Immunodiagnostic System

The VITROS® 3600 Immunodiagnostic System is designed for medium- to high-volume laboratories. The VITROS® 3600 System combines three proven VITROS® technologies into a single system, enabling reliable and accurate test results across a broad menu of immunoassays:

- MicroWell Technology with enhanced chemiluminescence enables exceptional assay performance with small sample volume requirements across a broad range of diseases.

- MicroSensor Technology automatically performs sample quality indices checks for the first time ever on an immunoassay system. This capability reduces the time, labour and error potential of manual interpretation.

- Intellicheck® Technology verifies analytical performance and reduces error potential by providing real-time operator notification and tracking.

The processing speed, on-board reagent capacities and uninterrupted workflow advantages of the system allow laboratories to address peak workloads and decrease turnaround times.

About Ortho Clinical Diagnostics

Ortho-Clinical Diagnostics, Inc., a Johnson & Johnson company, delivers the high quality in-vitro diagnostic products that give healthcare professionals around the world the knowledge they need to make better treatment decisions sooner. The company serves the global transfusion medicine community with donor screening and blood typing products to ensure every patient receives blood that's safe, the right type, and the right unit. Ortho Clinical Diagnostics also brings sophisticated information management, testing technologies, automation and interpretation tools to clinical laboratories worldwide to help them run more efficiently and improve patient care. For more information, visit http://www.orthoclinical.com

(*) Subject to local regulatory requirements

Source: Ortho Clinical Diagnostics a Johnson & Johnson company

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->